STAMFORD, Conn., April 23, 2018 -- Hexcel Corporation (NYSE:HXL) today announced that the Company’s Board of Directors has declared a regular quarterly cash dividend of $0.125 per share on the common stock of Hexcel, payable on May 11, 2018 to stockholders of record as of May 4, 2018.
Hexcel Corporation is a leading advanced composites company. It develops, manufactures and markets lightweight, high-performance structural materials, including carbon fibers, specialty reinforcements, prepregs and other fiber-reinforced matrix materials, honeycomb, adhesives, engineered core and composite structures, used in commercial aerospace, space and defense and industrial applications. Learn more at www.Hexcel.com.
| Contact Information | ||
| Kurt Goddard, Vice President – Investor Relations | ||
| (203) 352-6826 | ||
| [email protected] |


Samsung Chairman Lee Jae-yong Expected to Meet Nvidia CEO Jensen Huang on AI and Chip Partnership
DOJ Grand Jury Investigates UAW President Shawn Fain Ahead of Union Election
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
Zhipu AI Raises HK$31.37 Billion in Discounted Share Sale to Accelerate AI Growth
Kitron Q2 Revenue Beats Estimates as Defense Demand Lifts Growth
Nvidia Invests $500M in Firmus Technologies Ahead of Planned ASX IPO
Mizuho’s Top U.S. Industrials Stocks: Why Corteva and Stanley Black & Decker Stand Out
OpenAI Executive Fidji Simo to Step Down Amid Health Challenges Ahead of IPO
Morgan Stanley Names Marks & Spencer Top European Retail Pick, Sees Strong Upside
Bernstein Names IAG, Ryanair as Top European Airline Stocks Ahead of Earnings
SK Hynix’s $28B U.S. IPO Draws Strong Demand as AI Chip Boom Fuels Investor Interest
SK Hynix Soars 13% in Nasdaq Debut After Record $26.5 Billion IPO
Oil and LNG Tankers Turn Back as Strait of Hormuz Security Risks Escalate
Apple Sues OpenAI, Former Employees Over Alleged Trade Secret Theft
SK Hynix Prices Record U.S. ADR Offering at $149 After $200 Billion Investor Demand
Sino Biopharm Stock Rises After AstraZeneca Licensing Deal, GSK Partnership Expansion
Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI 



